0001019687-12-002047.txt : 20120605 0001019687-12-002047.hdr.sgml : 20120605 20120604185807 ACCESSION NUMBER: 0001019687-12-002047 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120604 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20120605 DATE AS OF CHANGE: 20120604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AETHLON MEDICAL INC CENTRAL INDEX KEY: 0000882291 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 133632859 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21846 FILM NUMBER: 12887398 BUSINESS ADDRESS: STREET 1: 8910 UNIVERSITY CENTER LANE, SUITE 660 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-459-7800 MAIL ADDRESS: STREET 1: 8910 UNIVERSITY CENTER LANE, SUITE 660 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: BISHOP EQUITIES INC DATE OF NAME CHANGE: 19930602 8-K 1 aethlon_8k-060412.htm CURRENT REPORT ON FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 4, 2012

AETHLON MEDICAL, INC.

(Exact name of registrant as specified in its charter)

Nevada

(State or other jurisdiction

of incorporation)

000-21846

(Commission File Number)

13-3632859

(IRS Employer

Identification Number)

8910 University Center Lane, Suite 660

San Diego, California

(Address of principal executive offices)

92122

(Zip Code)

Registrant’s telephone number, including area code: (858) 459-7800

Not applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):


£		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

£		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

£		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

£		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

FORWARD LOOKING STATEMENTS

This Form 8-K and other reports filed by Registrant from time to time with the Securities and Exchange Commission (collectively the "Filings") contain or may contain forward looking statements and information that are based upon beliefs of, and information currently available to, Registrant's management as well as estimates and assumptions made by Registrant's management. When used in the Filings the words "anticipate, "believe", "estimate", "expect", "future", "intend", "plan" or the negative of these terms and similar expressions as they relate to Registrant or Registrant's management identify forward looking statements. Such statements reflect the current view of Registrant with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to Registrant's industry, Registrant's operations and results of operations and any businesses that may be acquired by Registrant. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.

Although Registrant believes that the expectations reflected in the forward looking statements are reasonable, Registrant cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, Registrant does not intend to update any of the forward-looking statements to conform these statements to actual results.

ITEM 5.07	SUBMISSION OF MATTERS IN A VOTE OF SECURITY HOLDERS

The Registrant reported that at its Special Meeting of Stockholders held June 4, 2012 in San Diego, California, the stockholders approved an increase in authorized shares of the Registrant’s common stock from 250 million shares to 500 million shares.

Based on the report from the Inspector of Elections, approximately 84.4 percent of outstanding shares entitled to vote were present at the meeting and the Registrant’s stockholders approved the measure to increase the number of authorized shares, with affirmative votes in favor of the proposal of approximately 74.1 percent of the shares that were present at the meeting.

Final vote totals will be included in the Registrant’s annual report for the fiscal year ending March 31, 2012 to be filed with the United States Securities and Exchange Commission.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				AETHLON MEDICAL, INC.

				By: /s/ James A. Joyce
				James A. Joyce
		Dated: June 5, 2012		Chief Executive Officer